Denis Chem Lab Ltd Stock Price Today (NSE: DENISCHEM)
Fundamental Score
Denis Chem Lab Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Denis Chem Lab Ltd share price today is ₹56.54, down 4.91% on NSE/BSE as of 30 March 2026. Denis Chem Lab Ltd (DENISCHEM) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹120.83 (Cr). The 52-week high for DENISCHEM share price is ₹114.85 and the 52-week low is ₹59.22. At a P/E ratio of 16.88x, DENISCHEM is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 9.77% and a debt-to-equity ratio of 0.09.
Denis Chem Lab Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Denis Chem Lab Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Denis Chem Lab Share Price Analysis: A Growth Strategist's Perspective
The pharmaceutical industry is currently witnessing a shift towards greater self-reliance on APIs (Active Pharmaceutical Ingredients) and intermediates, driven by geopolitical factors and supply chain vulnerabilities. In this context, understanding the valuation and financial health of companies like Denis Chem Lab Ltd becomes crucial. This analysis delves into the current "Denis Chem Lab share price" of ₹77.0, considering its Price-to-Earnings (PE) ratio of 16.88 and Return on Capital Employed (ROCE) of 13.89%.
A PE ratio of 16.88 suggests that investors are paying ₹16.88 for every rupee of Denis Chem Lab's earnings. To contextualize this, we need to consider its peers. Comparing Denis Chem Lab Ltd with peers such as
Mankind Pharma Ltd in terms of management quality can offer insights. While Mankind Pharma often commands a premium valuation due to its perceived operational efficiencies and brand strength, it's important to assess whether Denis Chem Lab's management is effectively leveraging its assets and market opportunities to drive future growth. The qualitative aspect of management execution is critical for long term performance.The ROCE of 13.89% is a key indicator of profitability. It signifies the efficiency with which Denis Chem Lab is utilizing its capital to generate profits. This ROCE impacts the company's competitive moat. A consistently high ROCE suggests a stronger ability to reinvest profits at attractive rates, potentially widening the moat and providing a sustained competitive advantage. However, a ROCE of 13.89% must be compared against the cost of capital and industry standards to determine its true significance.
This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. It is an observation of publicly available data and is not a recommendation to buy, sell, or hold shares of Denis Chem Lab Ltd. Investors should conduct their own thorough due diligence before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Denis Chem Lab Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of DENISCHEM across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 16.88 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.09)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹44.90 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Below-Average Return on Equity (9.77%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-37.39%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Denis Chem Lab Ltd Financial Statements
Comprehensive financial data for Denis Chem Lab Ltd including income statement, balance sheet and cash flow
About DENISCHEM (Denis Chem Lab Ltd)
Denis Chem Lab Ltd is a pioneering force within the Indian pharmaceutical landscape, dedicated to the meticulous creation and distribution of sterile intravenous injectable solutio...ns for both human and animal healthcare needs. The company operates with a singular focus: to produce high-quality, life-saving medications delivered directly into the bloodstream. Their commitment extends beyond simply manufacturing; it embodies a dedication to precision, sterility, and efficacy, ensuring that each product meets the rigorous demands of modern medicine. From bustling urban hospitals to rural veterinary clinics, Denis Chem Lab aims to be a trusted provider of critical injectable therapies. The company’s diverse portfolio includes a spectrum of essential injectable medications, ranging from potent antibiotic treatments designed to combat severe infections, to carefully formulated diuretic solutions for fluid management. They also produce parenteral amino acid formulations to nourish patients unable to receive nutrition through conventional means, alongside plasma volume expanders crucial in emergency situations. Further strengthening their product line are specialized anti-anaerobic injections, fever-reducing anti-pyretic solutions, and sterile irrigation and dialysis fluids, all contributing to a comprehensive offering for a wide array of medical conditions. Each product is developed with scientific rigor and manufactured in state-of-the-art facilities. Beyond their own brand, Denis Chem Lab also extends their expertise to other pharmaceutical companies through contract manufacturing services. This collaborative approach leverages their advanced manufacturing capabilities and stringent quality control processes to support the broader healthcare industry. By partnering with third parties, Denis Chem Lab contributes to increasing the availability of vital medications, fostering innovation, and upholding the highest standards of pharmaceutical production. This dual focus – developing their own product line and providing contract manufacturing services – positions Denis Chem Lab as a versatile and reliable player in the pharmaceutical sector.
Company Details
Key Leadership
Corporate Events
Latest News
DENISCHEM Share Price: Frequently Asked Questions
What is the current share price of Denis Chem Lab Ltd (DENISCHEM)?
As of 30 Mar 2026, 12:02 pm IST, Denis Chem Lab Ltd share price is ₹56.54. The DENISCHEM stock has a market capitalisation of ₹120.83 (Cr) on NSE/BSE.
Is DENISCHEM share price Overvalued or Undervalued?
DENISCHEM share price is currently trading at a P/E ratio of 16.88x, compared to the industry average of 31.77x. Based on this relative valuation, the Denis Chem Lab Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of DENISCHEM share price?
The 52-week high of DENISCHEM share price is ₹114.85 and the 52-week low is ₹59.22. These values are updated daily from NSE/BSE price data.
What factors affect the Denis Chem Lab Ltd share price?
Key factors influencing DENISCHEM share price include quarterly earnings growth (Sales Growth: -3.45%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Denis Chem Lab Ltd a good stock for long-term investment?
Denis Chem Lab Ltd shows a 5-year Profit Growth of 13.93% and an ROE of 9.77%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.09 before investing in DENISCHEM shares.
How does Denis Chem Lab Ltd compare with its industry peers?
Denis Chem Lab Ltd competes with major peers in the Pharmaceuticals. Investors should compare DENISCHEM share price P/E of 16.88x and ROE of 9.77% against the industry averages to determine competitive standing.
What is the P/E ratio of DENISCHEM and what does it mean?
DENISCHEM share price has a P/E ratio of 16.88x compared to the industry average of 31.77x. Investors pay ₹17 for every ₹1 of annual earnings.
How is DENISCHEM performing according to Bull Run's analysis?
DENISCHEM has a Bull Run fundamental score of 32/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does DENISCHEM belong to?
DENISCHEM operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Denis Chem Lab Ltd share price.
What is Return on Equity (ROE) and why is it important for DENISCHEM?
DENISCHEM has an ROE of 9.77%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Denis Chem Lab Ltd generates profits from shareholders capital.
How is DENISCHEM debt-to-equity ratio and what does it indicate?
DENISCHEM has a debt-to-equity ratio of 0.09, which indicates conservative financing with low financial risk.
What is DENISCHEM dividend yield and is it a good dividend stock?
DENISCHEM offers a dividend yield of 1.72%, meaning you receive ₹1.72 annual dividend for every ₹100 invested in Denis Chem Lab Ltd shares.
How has DENISCHEM share price grown over the past 5 years?
DENISCHEM has achieved 5-year growth rates of: Sales Growth 5.03%, Profit Growth 13.93%, and EPS Growth 13.93%.
What is the promoter holding in DENISCHEM and why does it matter?
Promoters hold 38.98% of DENISCHEM shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Denis Chem Lab Ltd.
What is DENISCHEM market capitalisation category?
DENISCHEM has a market capitalisation of ₹121 crores, placing it in the Small-cap category.
How volatile is DENISCHEM stock?
DENISCHEM has a beta of N/A. A beta > 1 suggests the Denis Chem Lab Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is DENISCHEM operating profit margin trend?
DENISCHEM has a 5-year average Operating Profit Margin (OPM) of 10.82%, indicating the company's operational efficiency.
How is DENISCHEM quarterly performance?
Recent quarterly performance shows Denis Chem Lab Ltd YoY Sales Growth of -3.45% and YoY Profit Growth of -37.39%.
What is the institutional holding pattern in DENISCHEM?
DENISCHEM has FII holding of 0.01% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Denis Chem Lab Ltd stock.